NPI: 1447305032 · NORFOLK, VA 23507 · Adolescent and Children Mental Health Clinic/Center · NPI assigned 01/24/2007
Authorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
| Authorized Official | ABSHIRE, KATHRYN (SR VP/CFO) |
| Parent Organization | CHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC |
| NPI Enumeration Date | 01/24/2007 |
Other providers sharing the same authorized official: ABSHIRE, KATHRYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 31,539 | $424K |
| 2019 | 77,507 | $1.44M |
| 2020 | 71,446 | $2.63M |
| 2021 | 89,740 | $2.94M |
| 2022 | 77,150 | $2.60M |
| 2023 | 1,405 | $124K |
| 2024 | 203 | $23K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 41,844 | 13,544 | $2.52M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19,838 | 19,284 | $1.85M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 36,589 | 10,338 | $1.65M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 23,646 | 7,659 | $778K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 256 | 231 | $582K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,602 | 6,447 | $450K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,426 | 2,370 | $358K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,814 | 1,957 | $159K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,509 | 1,485 | $150K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1,031 | 1,009 | $105K |
| 97161 | 1,981 | 1,923 | $99K | |
| 90791 | Psychiatric diagnostic evaluation | 876 | 795 | $97K |
| 90837 | Psychotherapy, 53 minutes with patient | 1,016 | 519 | $95K |
| 97162 | 1,820 | 1,786 | $91K | |
| 90834 | Psychotherapy, 45 minutes with patient | 1,279 | 782 | $89K |
| 92526 | 1,420 | 598 | $85K | |
| 97535 | Self-care/home management training, each 15 minutes | 2,288 | 1,549 | $76K |
| 92587 | 3,298 | 3,212 | $70K | |
| 92579 | 1,421 | 1,399 | $64K | |
| 97116 | 2,612 | 1,189 | $62K | |
| 97542 | 927 | 882 | $61K | |
| 92567 | 3,859 | 3,762 | $58K | |
| 97165 | 1,342 | 1,302 | $58K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 5,757 | 5,260 | $46K |
| 99215 | Prolong outpt/office vis | 331 | 322 | $41K |
| 64643 | 296 | 267 | $32K | |
| 64642 | 305 | 282 | $32K | |
| 97760 | 381 | 349 | $27K | |
| 97016 | 966 | 350 | $25K | |
| 87631 | 4,687 | 4,584 | $25K | |
| 90832 | Psychotherapy, 30 minutes with patient | 402 | 299 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,926 | 3,792 | $17K |
| 94010 | 1,807 | 1,767 | $15K | |
| 97763 | 573 | 531 | $15K | |
| 97014 | 670 | 215 | $14K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4,673 | 4,610 | $12K |
| 96112 | 65 | 65 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 129 | 127 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14,832 | 14,203 | $9K |
| 80053 | Comprehensive metabolic panel | 8,018 | 7,594 | $9K |
| 93304 | 276 | 248 | $9K | |
| 80050 | General health panel | 3,277 | 3,251 | $9K |
| 96127 | 1,365 | 1,323 | $8K | |
| 99205 | Prolong outpt/office vis | 53 | 52 | $8K |
| 97010 | 4,238 | 1,802 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4,845 | 4,723 | $7K |
| 93321 | 938 | 841 | $6K | |
| 87486 | 4,688 | 4,585 | $6K | |
| 87581 | 4,690 | 4,585 | $6K | |
| 93325 | 2,021 | 1,744 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 141 | 140 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 7,222 | 7,092 | $5K |
| 92552 | 169 | 168 | $5K | |
| 80061 | Lipid panel | 6,713 | 6,650 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5,076 | 5,006 | $5K |
| 87507 | 380 | 367 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,098 | 5,022 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 76 | 29 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 807 | 789 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,860 | 2,805 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,969 | 2,888 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 6,300 | 6,189 | $4K |
| 96160 | 1,170 | 1,147 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,126 | 1,109 | $3K |
| 84439 | 4,706 | 4,604 | $3K | |
| 92556 | 80 | 79 | $3K | |
| 83020 | 1,032 | 1,011 | $3K | |
| 82728 | 2,295 | 2,246 | $3K | |
| 97033 | 112 | 38 | $3K | |
| 97750 | 30 | 26 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 59 | 50 | $2K |
| 95117 | 178 | 118 | $2K | |
| 93227 | 98 | 94 | $2K | |
| 97755 | 12 | 12 | $2K | |
| V5266 | Battery for use in hearing device | 269 | 247 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,296 | 4,133 | $2K |
| 82248 | 2,731 | 2,124 | $2K | |
| 87077 | 1,847 | 1,791 | $2K | |
| 83516 | 1,825 | 1,808 | $2K | |
| 85045 | 2,525 | 2,419 | $2K | |
| 82977 | 2,655 | 2,532 | $2K | |
| 80306 | 1,019 | 1,006 | $2K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 13 | 13 | $2K |
| 99170 | 13 | 12 | $2K | |
| 83735 | 1,028 | 883 | $2K | |
| 99233 | Prolong inpt eval add15 m | 23 | 12 | $1K |
| 82784 | 1,948 | 1,921 | $1K | |
| 82570 | 2,401 | 2,339 | $1K | |
| 84100 | 1,249 | 1,079 | $1K | |
| 96111 | 13 | 12 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,076 | 988 | $1K |
| 82043 | 1,606 | 1,579 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,472 | 1,457 | $1K |
| V5011 | Fitting/orientation/checking of hearing aid | 14 | 12 | $1K |
| 86003 | 574 | 527 | $1K | |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19 | 18 | $983.34 |
| 87186 | 1,275 | 1,241 | $939.74 | |
| 83550 | 807 | 794 | $891.00 | |
| 84460 | 747 | 731 | $855.95 | |
| 82247 | 1,882 | 1,278 | $839.65 | |
| 83540 | 1,038 | 1,022 | $828.14 | |
| 84450 | 745 | 729 | $785.00 | |
| 82565 | 577 | 566 | $709.39 | |
| 85027 | 1,017 | 974 | $702.88 | |
| 81025 | 986 | 955 | $682.00 | |
| 84146 | 348 | 338 | $587.16 | |
| 86140 | 2,719 | 2,635 | $554.87 | |
| 81001 | 2,075 | 1,991 | $530.45 | |
| 81003 | 3,201 | 3,152 | $529.71 | |
| 83655 | 4,206 | 4,175 | $519.19 | |
| 87070 | 863 | 832 | $517.02 | |
| 87506 | 14 | 14 | $473.38 | |
| 80076 | 548 | 534 | $433.68 | |
| 83001 | 343 | 339 | $372.05 | |
| 85610 | 571 | 444 | $367.87 | |
| 85652 | 2,661 | 2,588 | $325.38 | |
| 83970 | 24 | 24 | $297.20 | |
| 85007 | 656 | 620 | $287.42 | |
| 86480 | 105 | 104 | $278.90 | |
| 87660 | 277 | 271 | $266.82 | |
| 87480 | 277 | 271 | $252.70 | |
| 87510 | 277 | 271 | $252.70 | |
| 90785 | 18 | 17 | $237.24 | |
| 86038 | 422 | 403 | $217.67 | |
| 83002 | 291 | 288 | $216.71 | |
| 87101 | 331 | 327 | $208.20 | |
| 84156 | 750 | 718 | $204.96 | |
| 83615 | 157 | 150 | $202.48 | |
| 84550 | 364 | 346 | $195.36 | |
| 84402 | 163 | 160 | $160.44 | |
| 86592 | 1,395 | 1,383 | $109.28 | |
| 85730 | 155 | 151 | $100.97 | |
| 83690 | 258 | 251 | $81.29 | |
| 83519 | 13 | 13 | $66.24 | |
| 80197 | 15 | 12 | $49.44 | |
| 82465 | 260 | 251 | $39.20 | |
| 86803 | 67 | 67 | $38.52 | |
| 87340 | 75 | 73 | $37.20 | |
| 83993 | 17 | 15 | $35.34 | |
| 82785 | 115 | 105 | $32.92 | |
| 85018 | 908 | 905 | $31.95 | |
| 80324 | 25 | 25 | $27.28 | |
| 82670 | 119 | 116 | $25.15 | |
| 82150 | 114 | 110 | $17.49 | |
| 86665 | 13 | 12 | $16.33 | |
| 82947 | 24 | 24 | $14.16 | |
| 87807 | 74 | 70 | $11.79 | |
| 86706 | 67 | 67 | $9.67 | |
| 82272 | 17 | 15 | $7.62 | |
| 82550 | 29 | 25 | $5.86 | |
| 85660 | 12 | 12 | $4.96 | |
| J2357 | Injection, omalizumab, 5 mg | 15 | 12 | $0.16 |
| 36415 | Collection of venous blood by venipuncture | 58 | 57 | $0.00 |
| 97113 | 50 | 24 | $0.00 | |
| 82607 | 13 | 13 | $0.00 | |
| 86225 | 24 | 24 | $0.00 | |
| 84030 | 67 | 53 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 12 | 12 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 16 | 15 | $0.00 |